Integrated BioPharma Statistics
Total Valuation
INBP has a market cap or net worth of 9.86 million. The enterprise value is 8.72 million.
Market Cap | 9.86M |
Enterprise Value | 8.72M |
Important Dates
The last earnings date was Tuesday, February 11, 2025.
Earnings Date | Feb 11, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
INBP has 30.30 million shares outstanding. The number of shares has increased by 4.24% in one year.
Current Share Class | n/a |
Shares Outstanding | 30.30M |
Shares Change (YoY) | +4.24% |
Shares Change (QoQ) | +2.13% |
Owned by Insiders (%) | 15.36% |
Owned by Institutions (%) | 0.07% |
Float | 9.44M |
Valuation Ratios
The trailing PE ratio is 10.56.
PE Ratio | 10.56 |
Forward PE | n/a |
PS Ratio | 0.19 |
PB Ratio | 0.50 |
P/TBV Ratio | 0.50 |
P/FCF Ratio | 5.67 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.12, with an EV/FCF ratio of 5.02.
EV / Earnings | 9.40 |
EV / Sales | 0.17 |
EV / EBITDA | 3.12 |
EV / EBIT | 6.02 |
EV / FCF | 5.02 |
Financial Position
The company has a current ratio of 3.26, with a Debt / Equity ratio of 0.07.
Current Ratio | 3.26 |
Quick Ratio | 1.20 |
Debt / Equity | 0.07 |
Debt / EBITDA | 0.47 |
Debt / FCF | 0.76 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 4.85% and return on invested capital (ROIC) is 4.32%.
Return on Equity (ROE) | 4.85% |
Return on Assets (ROA) | 3.53% |
Return on Invested Capital (ROIC) | 4.32% |
Return on Capital Employed (ROCE) | 7.21% |
Revenue Per Employee | 354,585 |
Profits Per Employee | 6,313 |
Employee Count | 147 |
Asset Turnover | 2.03 |
Inventory Turnover | 4.05 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +30.49% in the last 52 weeks. The beta is 0.62, so INBP's price volatility has been lower than the market average.
Beta (5Y) | 0.62 |
52-Week Price Change | +30.49% |
50-Day Moving Average | 0.34 |
200-Day Moving Average | 0.26 |
Relative Strength Index (RSI) | 48.11 |
Average Volume (20 Days) | 23,086 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.15 |
Income Statement
In the last 12 months, INBP had revenue of 52.12 million and earned 928,000 in profits. Earnings per share was 0.03.
Revenue | 52.12M |
Gross Profit | 5.07M |
Operating Income | 1.45M |
Pretax Income | 1.46M |
Net Income | 928,000 |
EBITDA | 1.78M |
EBIT | 1.45M |
Earnings Per Share (EPS) | 0.03 |
Balance Sheet
The company has 2.46 million in cash and 1.32 million in debt, giving a net cash position of 1.14 million or 0.04 per share.
Cash & Cash Equivalents | 2.46M |
Total Debt | 1.32M |
Net Cash | 1.14M |
Net Cash Per Share | 0.04 |
Equity (Book Value) | 19.73M |
Book Value Per Share | 0.65 |
Working Capital | 12.58M |
Cash Flow
In the last 12 months, operating cash flow was 2.32 million and capital expenditures -576,000, giving a free cash flow of 1.74 million.
Operating Cash Flow | 2.32M |
Capital Expenditures | -576,000 |
Free Cash Flow | 1.74M |
FCF Per Share | 0.06 |
Margins
Gross margin is 9.73%, with operating and profit margins of 2.78% and 1.78%.
Gross Margin | 9.73% |
Operating Margin | 2.78% |
Pretax Margin | 2.79% |
Profit Margin | 1.78% |
EBITDA Margin | 3.42% |
EBIT Margin | 2.78% |
FCF Margin | 3.34% |
Dividends & Yields
INBP does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -4.24% |
Shareholder Yield | -4.24% |
Earnings Yield | 9.41% |
FCF Yield | 17.63% |
Stock Splits
The last stock split was on July 2, 1996. It was a reverse split with a ratio of 0.25.
Last Split Date | Jul 2, 1996 |
Split Type | Reverse |
Split Ratio | 0.25 |
Scores
INBP has an Altman Z-Score of 1.85. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.85 |
Piotroski F-Score | n/a |